Structure, Transmission, Diagnostic Symptoms, Host and Entry Mechanism of COVID-19: A Review

Author(s): Prashant Swapnil, Mukesh Meena*, Tansukh Barupal, Yashwant Sompura, Deepa Hada

Journal Name: Coronaviruses
The World's First International Journal Dedicated to Coronaviruses

Volume 2 , Issue 5 , 2021

Article ID: e300421188050
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


In Wuhan, China, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported and caused coronavirus disease 19 (COVID-19). The coronavirus infection is pathogenic and highly transmittable and spread quickly around the world by the human to human contact. Through genomic analysis, it has been revealed that the primary reservoir of SARS-CoV-2 is bats due to having severe acute respiratory syndrome-like (SARS-like) viruses phylogenetically. The viral infection is rapidly transmitted by the human to human contact, but the intermediate source of their origin and transfer is not known. To date, any clinically approved vaccine or antiviral drug has not been prepared against COVID-19. However, researchers and scientists have evaluated some broad-spectrum antiviral drugs against COVID-19 through clinical trials and they have found satisfactory clinical recovery. This review summarizes the comparative analysis of the emergence and pathogenicity of COVID-19, severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome coronavirus (MERS-CoV). This review is also focused on the development of effective vaccines or antidrug and also provides details related to an approach to practice therapeutic combinations to fight against this viral outbreak.

Keywords: COVID-19, SARS-CoV-2, glycoprotein, infection, symptoms, prevention.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 16 November, 2020
Article ID: e300421188050
Pages: 9
DOI: 10.2174/2666796701999201116213826

Article Metrics

PDF: 30